Stay updated on PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Sign up to get notified when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing Revision: v3.4.1, and a government funding status notice was removed with no changes to the trial details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:58:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Site-wide notices about funding status and a revision update (Revision: v3.4.1, replacing v3.4.0) were added; these do not modify study data, eligibility criteria, or other core information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:26:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display option, a new QC-related label (Last Update Submitted that Met QC Criteria), and a new revision tag (Revision: v3.4.0). Removed the previous QC label variant (Last Update Submitted that met QC Criteria), removed the No FEAR Act data label as a separate item, and adjusted capitalization for No FEAR Act Data and the older revision tag (Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T06:00:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added and replaces the previous revision, v3.3.3. This is an administrative update and does not alter study data or the information shown about the trial.
    Difference
    0.1%
    Check dated 2026-01-14T02:46:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Footer now displays 'Revision: v3.3.3'. The strings 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' are no longer present.
    Difference
    0.1%
    Check dated 2025-12-23T17:17:02.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 with no observable changes to study content or layout; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:20:07.000Z thumbnail image

Stay in the know with updates to PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.